Physician profile
Melissa Ducote
NPI 1679889349
$1,904.35
in general payments reported to CMS, 2019-2025
21 companies · $83.74 in 2025
The $83.74 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,011 · 2022: $485 · 2023: $290 · 2024: $35.19 · 2025: $83.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $327.93 | 2021-2023 | |
| Novo Nordisk INC | $260.63 | 2021-2023 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $189.43 | 2021-2022 | |
| Amgen INC. | $182.87 | 2021-2022 | |
| Lilly USA, LLC | $159.40 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $138.73 | 2021-2022 | |
| Boston Scientific Corporation | $100.43 | 2021 | |
| Pfizer INC. | $95.86 | 2021 | |
| Merck Sharp & Dohme LLC | $83.49 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $81.49 | 2021-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $43.56 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $43.34 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.31 | 2021-2025 | Jardiance |
| Sunovion Pharmaceuticals INC. | $31.06 | 2021 | |
| Abbott Laboratories | $29.06 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $20.49 | 2023 | |
| Dexcom, INC. | $19.39 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.34 | 2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $16.94 | 2022 | |
| Exact Sciences Corporation | $13.98 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Ducote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.